Tedious, Tiresome, and Dull: An Unrecognized Problem That We Can Solve

por Polonsky, William H.
Publicado 2021

Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients: Right answer, but wrong question: self-monitoring of blood glucose can be clinically valuable for non...

por Polonsky, William H., Fisher, Lawrence
Publicado 2013

Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors

por Polonsky, William H, Henry, Robert R
Publicado 2016

Impact of Real-Time Continuous Glucose Monitoring Data Sharing on Quality of Life and Health Outcomes in Adults with Type 1 Diabetes

por Polonsky, William H., Fortmann, Addie L.
Publicado 2021

Depression in Diabetes: Have We Been Missing Something Important?

por Gonzalez, Jeffrey S., Fisher, Lawrence, Polonsky, William H.
Publicado 2011

The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older

por Polonsky, William H., Peters, Anne L., Hessler, Danielle
Publicado 2016

When Is Diabetes Distress Clinically Meaningful?: Establishing cut points for the Diabetes Distress Scale

por Fisher, Lawrence, Hessler, Danielle M., Polonsky, William H., Mullan, Joseph
Publicado 2012

The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study()

por Fisher, Lawrence, Polonsky, William, Asuni, Adijat, Jolly, Yasmin, Hessler, Danielle
Publicado 2020

Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study

por Gilbert, Timothy R., Noar, Adam, Blalock, Olivia, Polonsky, William H.
Publicado 2021

Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study

por Polonsky, William, Gamble, Cory, Iyer, Neeraj, Martin, Mona, Hamersky, Carol
Publicado 2021

Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Pract...

por Polonsky, William H., Arora, Riya, Faurby, Mads, Fernandes, João, Liebl, Andreas
Publicado 2021

Improved Treatment Engagement Among Patients with Diabetes Treated with Insulin Glargine 300 U/mL Who Participated in the COACH Support Program

por Goldman, Jennifer D., Gill, Jasvinder, Horn, Tony, Reid, Timothy, Strong, Jodi, Polonsky, William H.
Publicado 2018

Temporal trends in the prevalence and incidence of depression and the interplay of comorbidities in patients with young- and usual-onset type 2 diabetes from the USA and the UK

por Dibato, John, Montvida, Olga, Ling, Joanna, Koye, Digsu, Polonsky, William H., Paul, Sanjoy K.
Publicado 2022

Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature rev...

por Evans, Marc, Engberg, Susanne, Faurby, Mads, Fernandes, João Diogo Da Rocha, Hudson, Pollyanna, Polonsky, William
Publicado 2021

Quality of life in patients with type 2 diabetes after switching to insulin degludec: results from a cross-sectional survey

por Uzoigwe, Chioma, Radin, Michael, Hamersky, Carol M., DeKoven, Mitch, Holt, Cassie, Karkare, Swapna, Polonsky, William H.
Publicado 2021

The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with type 2 diabetes: Design of the Structured Testing Program (STeP) Study, a cluster-rand...

por Polonsky, William, Fisher, Lawrence, Schikman, Charles, Hinnen, Deborah, Parkin, Christopher, Jelsovsky, Zhihong, Amstutz, Linda, Schweitzer, Matthias, Wagner, Robin
Publicado 2010

When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation

por Weatherall, James, Polonsky, William H., Lanar, Sally, Knoble, Naomi, Håkan-Bloch, Jonas, Constam, Elisabeth, Philis-Tsimikas, Athena, Marrel, Alexia
Publicado 2018

Use of Connected Pen as a Diagnostic Tool to Evaluate Missed Bolus Dosing Behavior in People with Type 1 and Type 2 Diabetes

por Edwards, Stephanie, He, Xuanyao, Wang, Wenjie, Poon, Jiat-Ling, Meadows, Eric, Price, David, Johnson, Jennal, Wolpert, Howard, Polonsky, William
Publicado 2022

Semaglutide improves health‐related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6)

por Jódar, Esteban, Michelsen, Marie, Polonsky, William, Réa, Rosangela, Sandberg, Anna, Vilsbøll, Tina, Warren, Mark, Harring, Signe, Ziegler, Uwe, Bain, Stephen
Publicado 2020

Improved patient‐reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial

por Polonsky, William H., Giorgino, Francesco, Rosenstock, Julio, Whitmire, Katherine, Lew, Elisheva, Coudert, Mathieu, Alvarez, Agustina, Nicholls, Charlie, McCrimmon, Rory J.
Publicado 2022